FRSH
Freshworks Inc.
FRSH has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over FRSH overall, supported by stronger modeled upside and stronger fundamentals.
FRSH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Strong |
FRSH's revenue, profitability, cash flow and balance sheet are all currently healthy.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
FRSH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | $9.39 | -26% |
| Forward | 15x | $12.67 | — |
| Fair | 16x | $11.78 | -7.1% |
| Current | 18x | $12.67 | — |
| Expensive | 20x | $14.57 | +15% |
Historical ranges are pointers, not guarantees.
FRSH's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over FRSH in the historical PE scenario, which offers more potential upside but is not a forecast.
FRSH Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for FRSH, with profitability improving.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
FRSH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.84 | +17% |
| Q3 2026 | $0.72 | +$0.82 |
| Q2 2026 | $0.63 | +$0.81 |
| Q1 2026 | $0.61 | +$0.85 |
| Q4 2025 | $0.63 | +$0.95 |
| Q3 2025 | -$0.10 | +$0.24 |
| Q2 2025 | -$0.18 | +$0.17 |
| Q1 2025 | -$0.24 | +$0.16 |
| Q4 2024 | -$0.32 | +$0.15 |
FRSH has returned to profit: it earned $0.72 per share over the past year, after losing money the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over FRSH in the latest year-over-year earnings comparison.
FRSH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $245.4M | +14% |
| Q2 2026 | $237.4M | +16% |
| Q1 2026 | $228.6M | +16% |
| Q4 2025 | $222.7M | +14% |
| Q3 2025 | $215.1M | +15% |
| Q2 2025 | $204.7M | +18% |
| Q1 2025 | $196.3M | +19% |
| Q4 2024 | $194.6M | +22% |
FRSH's revenue has grown year over year every quarter since late 2020: $245M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | +15 points |
| Q2 2026 | 2.5% | +6.8 points |
| Q1 2026 | -3.5% | +1.8 points |
| Q4 2025 | 18% | +30 points |
| Q3 2025 | -3.5% | +17 points |
| Q2 2025 | -4.2% | +21 points |
| Q1 2025 | -5.3% | +14 points |
| Q4 2024 | -12% | +13 points |
FRSH's operating margin was 12% last quarter, up 15 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over FRSH on profitability, with a higher operating margin.
FRSH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $74.9M | +21% |
| Q2 2026 | $53.5M | -8.1% |
| Q1 2026 | $58.5M | +3.2% |
| Q4 2025 | $60.1M | +66% |
| Q3 2025 | $61.7M | +49% |
| Q2 2025 | $58.2M | +71% |
| Q1 2025 | $56.7M | +42% |
| Q4 2024 | $36.3M | +22% |
FRSH generated $247M in free cash flow over the past year, up 16% from the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
FRSH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.4% | -6.6M shares |
| 1 year | -6.9% | -19.8M shares |
| 3 years | -9.4% | -27.8M shares |
| 5 years | +5.3% | +13.5M shares |
| Available history | +1468% | +249M shares |
FRSH has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $27.2M |
| Q2 2026 | $159M |
| Q1 2026 | $48.4M |
| Q4 2025 | — |
| Q3 2025 | $159.1M |
| Q2 2025 | $113.6M |
| Q1 2025 | $113.6M |
| Q2 2021 | — |
FRSH spent $235M buying back its own shares over the past year.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
FRSH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.8x | Net Cash |
| Q2 2026 | -8.3x | Net Cash |
| Q1 2026 | -12.8x | Net Cash |
| Q4 2025 | -14.6x | Net Cash |
| Q2 2021 | -122.9x | Net Cash |
| Q1 2021 | -101.8x | Net Cash |
| Q1 2019 | 6.2x | High |
FRSH has the edge over SNDK on leverage, with a lower net debt burden relative to earnings.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
FRSH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.8 | Neutral |
| Stochastic | 46.5 | Neutral |
FRSH's weekly RSI is 53 (neutral) and its Stochastic is 47 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
FRSH PE vs Technology Sector
| Metric | FRSH | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 28x | 37% below |
| PE % | 62 | 45 | 17 pts above |
FRSH is trading at 18x earnings, a 37% discount to the Technology sector's median of 28x, though its earnings don't support one.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over FRSH on valuation relative to its sector.
FRSH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.5 | 6.1% below |
| 20 week MA | $12.5 | 1.6% above |
| 50 week MA | $10.8 | 18% above |
| 100 week MA | $12.5 | 1.4% above |
| 200 week MA | $14.5 | 13% below |
FRSH has stronger trend alignment. FRSH is above 3 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
FRSH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $46.8 | $27.9 | -40% |
| 2022 | $27.9 | $13.8 | -50% |
| 2023 | $13.8 | $23.5 | +70% |
| 2024 | $23.5 | $15.9 | -32% |
| 2025 | $15.9 | $12.4 | -22% |
| 2026 YTD | $12.4 | $12.7 | +2.2% |
FRSH has finished lower in four of the last five years. It's up 2.2% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over FRSH on returns for 2026, with the stronger performance.